Cargando…
286P Breakthrough COVID-19 infections in patients with cancer from a prospective study of COVID-19 vaccine response
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719676/ http://dx.doi.org/10.1016/j.annonc.2022.10.312 |
| _version_ | 1784843377859100672 |
|---|---|
| author | Body, A. Ahern, E.S. Lal, L. Abdulla, H. Opat, S. Downie, P. Leahy, M. Fuentes-Bolanos, N. Padhye, B. Hamad, N. Milch, V. Segelov, E. |
| author_facet | Body, A. Ahern, E.S. Lal, L. Abdulla, H. Opat, S. Downie, P. Leahy, M. Fuentes-Bolanos, N. Padhye, B. Hamad, N. Milch, V. Segelov, E. |
| author_sort | Body, A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9719676 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-97196762022-12-05 286P Breakthrough COVID-19 infections in patients with cancer from a prospective study of COVID-19 vaccine response Body, A. Ahern, E.S. Lal, L. Abdulla, H. Opat, S. Downie, P. Leahy, M. Fuentes-Bolanos, N. Padhye, B. Hamad, N. Milch, V. Segelov, E. Ann Oncol Article Published by Elsevier Ltd. 2022-11 2022-12-04 /pmc/articles/PMC9719676/ http://dx.doi.org/10.1016/j.annonc.2022.10.312 Text en Copyright © 2022 Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Body, A. Ahern, E.S. Lal, L. Abdulla, H. Opat, S. Downie, P. Leahy, M. Fuentes-Bolanos, N. Padhye, B. Hamad, N. Milch, V. Segelov, E. 286P Breakthrough COVID-19 infections in patients with cancer from a prospective study of COVID-19 vaccine response |
| title | 286P Breakthrough COVID-19 infections in patients with cancer from a prospective study of COVID-19 vaccine response |
| title_full | 286P Breakthrough COVID-19 infections in patients with cancer from a prospective study of COVID-19 vaccine response |
| title_fullStr | 286P Breakthrough COVID-19 infections in patients with cancer from a prospective study of COVID-19 vaccine response |
| title_full_unstemmed | 286P Breakthrough COVID-19 infections in patients with cancer from a prospective study of COVID-19 vaccine response |
| title_short | 286P Breakthrough COVID-19 infections in patients with cancer from a prospective study of COVID-19 vaccine response |
| title_sort | 286p breakthrough covid-19 infections in patients with cancer from a prospective study of covid-19 vaccine response |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719676/ http://dx.doi.org/10.1016/j.annonc.2022.10.312 |
| work_keys_str_mv | AT bodya 286pbreakthroughcovid19infectionsinpatientswithcancerfromaprospectivestudyofcovid19vaccineresponse AT ahernes 286pbreakthroughcovid19infectionsinpatientswithcancerfromaprospectivestudyofcovid19vaccineresponse AT lall 286pbreakthroughcovid19infectionsinpatientswithcancerfromaprospectivestudyofcovid19vaccineresponse AT abdullah 286pbreakthroughcovid19infectionsinpatientswithcancerfromaprospectivestudyofcovid19vaccineresponse AT opats 286pbreakthroughcovid19infectionsinpatientswithcancerfromaprospectivestudyofcovid19vaccineresponse AT downiep 286pbreakthroughcovid19infectionsinpatientswithcancerfromaprospectivestudyofcovid19vaccineresponse AT leahym 286pbreakthroughcovid19infectionsinpatientswithcancerfromaprospectivestudyofcovid19vaccineresponse AT fuentesbolanosn 286pbreakthroughcovid19infectionsinpatientswithcancerfromaprospectivestudyofcovid19vaccineresponse AT padhyeb 286pbreakthroughcovid19infectionsinpatientswithcancerfromaprospectivestudyofcovid19vaccineresponse AT hamadn 286pbreakthroughcovid19infectionsinpatientswithcancerfromaprospectivestudyofcovid19vaccineresponse AT milchv 286pbreakthroughcovid19infectionsinpatientswithcancerfromaprospectivestudyofcovid19vaccineresponse AT segelove 286pbreakthroughcovid19infectionsinpatientswithcancerfromaprospectivestudyofcovid19vaccineresponse |